Answers are grounded in this paper and cite their sources.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, largely due to late diagnosis and treatment resistance. Metabolic reprogramming is a hallmark of cancer, but the mechanisms underlying metabolic heterogeneity in PDAC remain unclear. This study aimed to explore the relationship between metabolic tumor volume (MTV) and molecular features in PDAC to identify key regulators of metabolic phenotypes. We analyzed high-throughput transcriptomic data from 14 PDAC samples with matched adjacent tissues and single-cell RNA sequencing data from 6 PDAC samples. Samples were stratified by MTV values from PET-CT imaging. Differentially expressed genes between MTV high and MTV low groups were identified and functionally annotated. Single-cell analysis characterized cell-type specific expression patterns, cell-cell communication networks, and metabolic profiles. Weighted gene co-expression network analysis (WGCNA) was used to identify key regulatory modules associated with metabolic phenotypes. PLEC expression was validated by immunohistochemistry (IHC) in an independent cohort of 8 PDAC patients. In 6 of these cases, six-marker multiplex immunofluorescence (panCK, PLEC, CD8, FOXP3, CD68, PD-L1) was performed to resolve PLEC expression within tumor and immune compartments and to characterize the spatial immune microenvironment. Comparison of MTVʰⁱᵍʰ and MTVˡᵒʷ tumors identified 73 shared differentially expressed genes, among which PLEC was the top upregulated candidate. PLEC co-expressed with extracellular matrix components and was enriched in both cancer-associated fibroblasts (CAFs) and tumor cells. At single-cell resolution, PLECʰⁱᵍʰ fibroblasts displayed a myofibroblastic, matrix-remodeling phenotype, whereas PLECʰⁱᵍʰ tumor cells showed heightened metabolic reprogramming, with enhanced glycolysis and oxidative phosphorylation. Cell-cell communication analysis implicated PTN–SDC4/SDC1, MDK–SDC1, WNT, and TGF-β signaling in PLEC-associated tumor–stroma crosstalk. IHC confirmed elevated PLEC expression in PDAC tissues. Multiplex immunofluorescence showed PLEC co-localization predominantly with panCK + tumor cells and focally with CD68 + macrophages, but not with PD-L1. Integrated bulk and single-cell transcriptomic analyses identified mesenchymal programs in CAFs and malignant epithelial cells as major correlates of MTV in PDAC, with PLEC emerging as a candidate hub gene. Spatial imaging showed enrichment of PLEC-positive and PanCK/PLEC double-positive cells in tumor regions, and IHC further confirmed PLEC expression in pancreatic tumor cells. PLEC may therefore serve as a potential molecular correlate of the metabolic phenotype in PDAC.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: